The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics

被引：0
|
作者：
Brett R. Cowan
Alistair A. Young
Craig Anderson
Robert N. Doughty
Rungroj Krittayaphong
Eva Lonn
Thomas H. Marwick
Chris M. Reid
John E. Sanderson
Roland E. Schmieder
Koon Teo
Angela K. Wadham
Stephen G. Worthley
Cheuk-Man Yu
Salim Yusuf
Garry L. Jennings
机构：
[1] University of Auckland,Auckland MRI Research Group
[2] University of Auckland,Clinical Trials Research Unit, School of Population Health
[3] University of Sydney and Royal Prince Alfred Hospital,The George Institute For International Health
[4] University of Auckland,Department of Medicine
[5] Siriraj Hospital,Division of Cardiology, Department of Medicine
[6] McMaster University,Department of Medicine, Division of Cardiology and Population Health Research Institute
[7] University of Queensland,Department of Medicine
[8] University of Birmingham,Department of Cardiovascular Medicine
[9] Friedrich-Alexander-University,Department of Nephrology and Hypertension
[10] Baker IDI Heart and Diabetes Institute,CCRE Therapeutics
[11] Monash University,Cardiovascular Investigation Unit
[12] Royal Adelaide Hospital,Department of Medicine and Therapeutics
[13] The Chinese University of Hong Kong,Department of Anatomy with Radiology
[14] The University of Auckland,undefined
来源：
Clinical Research in Cardiology | 2009年 / 98卷
关键词：
Cardiac MRI; ONTARGET; TRANSCEND; Trials; Left ventricular dysfunction; Telmisartan; Ramipril;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 11 条
  • [1] The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics
    Cowan, Brett R.
    Young, Alistair A.
    Anderson, Craig
    Doughty, Robert N.
    Krittayaphong, Rungroj
    Lonn, Eva
    Marwick, Thomas H.
    Reid, Chris M.
    Sanderson, John E.
    Schmieder, Roland E.
    Teo, Koon
    Wadham, Angela K.
    Worthley, Stephen G.
    Yu, Cheuk-Man
    Yusuf, Salim
    Jennings, Garry L.
    CLINICAL RESEARCH IN CARDIOLOGY, 2009, 98 (07) : 421 - 433
  • [2] Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)
    Kappert, Kai
    Boehm, Michael
    Schmieder, Roland
    Schumacher, Helmut
    Teo, Koon
    Yusuf, Salim
    Sleight, Peter
    Unger, Thomas
    CIRCULATION, 2012, 126 (08) : 934 - U76
  • [3] Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients:: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)
    Boehm, Michael
    Baumhaekel, Manus
    Probstfield, Jeffrey L.
    Schmieder, Roland
    Yusuf, Salim
    Zhao, Feng
    Koon, Teo
    AMERICAN HEART JOURNAL, 2007, 154 (01) : 94 - 101
  • [4] Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating Telmisartan, Ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials
    Teo, KK
    AMERICAN HEART JOURNAL, 2004, 148 (01) : 52 - 61
  • [5] Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
    Verdecchia, Paolo
    Sleight, Peter
    Mancia, Giuseppe
    Fagard, Robert
    Trimarco, Bruno
    Schmieder, Roland E.
    Kim, Jae-Hyung
    Jennings, Garry
    Jansky, Petr
    Chen, Jyh-Hong
    Liu, Lisheng
    Gao, Peggy
    Probstfield, Jeffrey
    Teo, Koon
    Yusuf, Salim
    CIRCULATION, 2009, 120 (14) : 1380 - 1389
  • [6] Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials
    Boehm, Michael
    Baumhaekel, Magnus
    Teo, Koon
    Sleight, Peter
    Probstfield, Jeffrey
    Gao, Peggy
    Mann, Johannes F.
    Diaz, Rafael
    Dagenais, Gilles R.
    Jennings, Garry L. R.
    Liu, Lisheng
    Jansky, Petr
    Yusuf, Salim
    CIRCULATION, 2010, 121 (12) : 1439 - U114
  • [7] Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant Subjects With Cardiovascular Disease (ONTARGET/TRANSCEND) Trials Editorial Comment
    Seftel, Allen
    JOURNAL OF UROLOGY, 2010, 184 (04): : 1454 - 1455
  • [8] Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies
    Verdecchia, Paolo
    Dagenais, Gilles
    Healey, Jeff
    Gao, Peggy
    Dans, Antonio L.
    Chazova, Irina
    Binbrek, Azan S.
    Iacobellis, Gianluca
    Ferreira, Rafael
    Holwerda, Nicolaas
    Karatzas, Nicholas
    Keltai, Matyas
    Mancia, Giuseppe
    Sleight, Peter
    Teo, Koon
    Yusuf, Salim
    JOURNAL OF HYPERTENSION, 2012, 30 (05) : 1004 - 1014
  • [9] Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
    Horn, S.
    JOURNAL FUR HYPERTONIE, 2013, 17 (02): : 74 - 75
  • [10] Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
    Mancia, Giuseppe
    Schumacher, Helmut
    Redon, Josep
    Verdecchia, Paolo
    Schmieder, Roland
    Jennings, Garry
    Yusoff, Khalid
    Ryden, Lars
    Liu, G. Lisheng
    Teo, Koon
    Sleight, Peter
    Yusuf, Salim
    CIRCULATION, 2011, 124 (16) : 1727 - U94
12